Is progression-free survival associated with a better health-related quality of life in patients with lung cancer? Evidence from two randomised trials with afatinib.
Saved in:
| Title: | Is progression-free survival associated with a better health-related quality of life in patients with lung cancer? Evidence from two randomised trials with afatinib. |
|---|---|
| Authors: | Griebsch I; Boehringer Ingelheim GmbH, Ingelheim, Germany., Palmer M; Keele University, Keele, UK., Fayers PM; Institute of Applied Health Sciences, University of Aberdeen, Scotland, UK.; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Ellis S; Independent Statistical Consultant, Cheshire, UK. |
| Source: | BMJ open [BMJ Open] 2014 Oct 31; Vol. 4 (10), pp. e005762. Date of Electronic Publication: 2014 Oct 31. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2044-6055 |
|---|---|
| DOI: | 10.1136/bmjopen-2014-005762 |
